MAPT and Alzheimer disease: Using a cohort of AD patient brains that have undergone extensive post-mortem neuropathology analysis, we show that tau and Aβ levels are individually upregulated in these patients, irrespective of APOE genotype, though interestingly, α-synuclein pathology is slightly more predominant in APOE4 + individuals.